Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
RVMD
RVMD
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
RVMD News
Form 144: Revolution Medicines (RVMD.US) Executive Plans to Sell $3.58 Million in Common Stock
4d ago
moomoo
DAFNA Capital Management Reduces Stake in Biotechnology ETF
Mar 21 2026
NASDAQ.COM
DAFNA Capital Management Reduces Stake in iShares Biotechnology ETF
Mar 21 2026
Fool
RBC Capital Markets Lists 13 Biotechs Likely to Attract Takeover Interest
Mar 19 2026
seekingalpha
REVOLUTION MEDICINES INC: UBS Increases Price Target from $71 to $145
Feb 27 2026
moomoo
Revolution Medicines Q4 2025 Earnings Call Highlights
Feb 26 2026
seekingalpha
Revolution Medicines Reports Q4 2025 Financial Results
Feb 25 2026
seekingalpha
Stock Movers: Nvidia, Paramount, First Solar, Workday, Axon, HP Inc., Lucid, and Others
Feb 25 2026
Barron's
Revolution Medicines Set to Announce Q4 Earnings Results
Feb 24 2026
seekingalpha
a16z Capital Management Acquires Navan Shares
Feb 18 2026
Fool
a16z Capital Management Acquires Navan Shares
Feb 18 2026
NASDAQ.COM
Surge in Options Volume for BLSH and MDB Stocks
Feb 09 2026
NASDAQ.COM
RVMD Options Contract Analysis and Investment Opportunities
Jan 30 2026
NASDAQ.COM
Market Sentiment Improves as Stocks Rise
Jan 27 2026
Benzinga
Revolution Medicines Shares Plunge 17% After Merck Acquisition Talks Stall
Jan 27 2026
Fool
Merck Withdraws from Revolution Medicines Acquisition Talks
Jan 27 2026
NASDAQ.COM
Show More News
